We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$28.5M
(+9.6%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
243
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$3.29M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.96M |
| 3 |
Apple
AAPL
|
+$1.92M |
| 4 |
Vaxcyte
PCVX
|
+$1.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$5.11M |
| 2 |
Amazon
AMZN
|
+$4.12M |
| 3 |
Airbnb
ABNB
|
+$2.92M |
| 4 |
Analog Devices
ADI
|
+$2.79M |
| 5 |
KE Holdings
BEKE
|
+$2.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.8% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Healthcare | 19.26% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
SIGA Technologies
SIGA
$206M
| $4.72K | ﹤0.01% |
934
-55
| -6% | -$313 |
|
377
Xeris Biopharma Holdings
XERS
$1.55B
| $4.71K | ﹤0.01% |
1,799
-43
| -2% | -$109 |
|
378
Wave Life Sciences
WVE
$1.03B
| $4.69K | ﹤0.01% |
1,289
-36
| -3% | -$145 |
|
379
Design Therapeutics
DSGN
$917M
| $4.62K | ﹤0.01% |
733
-25
| -3% | -$153 |
|
|
BLUE
380
DELISTED
bluebird bio
BLUE
| $4.59K | ﹤0.01% |
70
| – | – |
|
381
Omeros
OMER
$992M
| $4.48K | ﹤0.01% |
824
-26
| -3% | -$152 |
|
382
Monte Rosa Therapeutics
GLUE
$1.36B
| $4.43K | ﹤0.01% |
647
-9
| -1% | -$58 |
|
383
MacroGenics
MGNX
$256M
| $4.34K | ﹤0.01% |
811
-22
| -3% | -$136 |
|
|
CNTA
384
DELISTED
Centessa Pharmaceuticals
CNTA
| $4.28K | ﹤0.01% |
691
-21
| -3% | -$100 |
|
|
KLRS
385
Kalaris Therapeutics
KLRS
$93.7M
| $4.17K | ﹤0.01% |
53
-2
| -4% | -$190 |
|
386
Atea Pharmaceuticals
AVIR
$405M
| $4.09K | ﹤0.01% |
1,093
-36
| -3% | -$135 |
|
|
OMGA
387
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $4.04K | ﹤0.01% |
721
-25
| -3% | -$196 |
|
388
ALX Oncology
ALXO
$278M
| $4.03K | ﹤0.01% |
536
-16
| -3% | -$105 |
|
|
NIU
389
Niu Technologies
NIU
$162M
| $3.98K | ﹤0.01% |
1,000
| – | – |
|
390
Immuneering
IMRX
$328M
| $3.88K | ﹤0.01% |
383
+25
| +7% | +$240 |
|
391
Humacyte
HUMA
$179M
| $3.88K | ﹤0.01% |
1,355
-43
| -3% | -$155 |
|
392
Foghorn Therapeutics
FHTX
$394M
| $3.86K | ﹤0.01% |
548
-18
| -3% | -$126 |
|
393
Precigen
PGEN
$2.45B
| $3.85K | ﹤0.01% |
3,349
-52
| -2% | -$61 |
|
394
Tango Therapeutics
TNGX
$4.31B
| $3.85K | ﹤0.01% |
1,158
-37
| -3% | -$133 |
|
395
PMV Pharmaceuticals
PMVP
$67.2M
| $3.76K | ﹤0.01% |
600
-18
| -3% | -$94 |
|
396
AtaiBeckley Inc
ATAI
$2.68B
| $3.74K | ﹤0.01% |
2,175
-73
| -3% | -$134 |
|
397
Sutro Biopharma
STRO
$353M
| $3.68K | ﹤0.01% |
79
+1
| +1% | +$50 |
|
398
Phibro Animal Health
PAHC
$1.37B
| $3.66K | ﹤0.01% |
267
-9
| -3% | -$129 |
|
|
IGMS
399
DELISTED
IGM Biosciences
IGMS
| $3.57K | ﹤0.01% |
387
-8
| -2% | -$90 |
|
|
KYNB
400
Kyntra Bio
KYNB
$28.7M
| $3.45K | ﹤0.01% |
51
| – | – |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q2 2023 Portfolio in Review
As of Q2 2023, China Universal Asset Management Company held 465 positions worth $324M, up 9.6% from $295M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company's Q2 2023 filing shows 18 new, 159 increased, 243 reduced and 13 closed positions. Its largest new stake was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M. The largest sale was iQIYI, an estimated $5.11M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q2 2023 buy was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M.
- China Universal Asset Management Company added most to Alnylam Pharmaceuticals in Q2 2023, an estimated $1.96M increase.
- China Universal Asset Management Company's biggest Q2 2023 reduction was iQIYI, cutting an estimated $5.11M.
- China Universal Asset Management Company fully exited Block Inc in Q2 2023, selling an estimated $1.35M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $324M portfolio in Q2 2023.
- China Universal Asset Management Company opened 18 new positions and closed 13 in Q2 2023.
- China Universal Asset Management Company's portfolio value rose 9.6% quarter-over-quarter to $324M.
Based on China Universal Asset Management Company's 13F filing for Q2 2023, filed 28 Jul 2023.